JPMorgan and Piper Jaffray are joint bookrunning managers for deal
By Devika Patel
Knoxville, Tenn., Nov. 22 - Oxford Immunotec Global plc said it priced its $64.32 million initial public offering of stock with a $9.65 million greenshoe. The deal was announced Oct. 15.
The company will sell 5.36 million ordinary shares at $12.00 per share.
J.P. Morgan Securities LLC and Piper Jaffray & Co. are the joint bookrunning managers.
Proceeds will be used to hire additional sales, marketing and customer service personnel and expand marketing programs, for research and development programs, debt repayment, working capital and other general corporate purposes.
The diagnostics company is based in Abingdon, England. The company intends to list its common stock on the Nasdaq stock exchange under the symbol "OXFD."
| Issuer: | Oxford Immunotec Global plc
|
| Issue: | Ordinary stock
|
| Amount: | $64.32 million
|
| Greenshoe: | $9,648,000
|
| Shares: | 5.36 million
|
| Price: | $12.00
|
| Warrants: | No
|
| Bookrunners: | J.P. Morgan Securities LLC and Piper Jaffray & Co.
|
| Co-managers: | Cowen and Co., LLC and Robert W. Baird & Co. Inc.
|
| Announcement date: | Oct. 15
|
| Pricing date: | Nov. 22
|
| Stock exchange: | Nasdaq: OXFD
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
